Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

ADHD symptoms in autism: Cognition, behavior, treatment  

This project will evaluate cognitive and behavioral functioning and co-occurring psychiatric symptoms in ASD children ages 7-12, both with and without symptoms of Attention Deficit Hyperactivitv Disorder (ADHD). The cognitive and behavioral response to placebo, low, medium, and high doses of methylphenidate (MPH) in children with Autism/ADHD will also be studied in a medication treatment trial, using a double-blind, placebo-controlled, crossover design to determine optimal MPH dosages. The primary goals of the proposed research are to characterize ADHD in school-aged children with Autistic Disorder (DSM-IV) and to assess their cognitive and behavioral response to MPH. Project Status


Funder National Institutes of Health
Fiscal Year Funding $271,086.00
Project Number 5R01MH072263-05
Principal Investigator Pearson, Deborah
Received ARRA Funding? No
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Interventions)
Strategic Plan Objective Yellow dot: Objective has some degree of funding, but less than the recommended amount. 4LC. Conduct at least one study to evaluate the safety and effectiveness of medications commonly used in the treatment of co-occurring conditions or specific behavioral issues in people with ASD by 2015. IACC Recommended Budget: $10,000,000 over 5 years.
Federal or Private? Federal
Institution University of Texas Health Science Center at Houston
State/Country Texas
Web Link 1 ADHD symptoms in autism: Cognition, behavior, treatment (External web link)
Web Link 2 No URL available.
Web Link 3 No URL available.
History/Related Projects ADHD symptoms in autism: Cognition, behavior, treatment | $273,390.00 | 2008 | R01MH072263-04